Skip to content

Efficacy and prognosis of warm acupuncture combined with cardiac rehabilitation in patients with chronic heart failure after AMI

Efficacy and prognosis of warm acupuncture combined with cardiac rehabilitation in patients with chronic heart failure after AMI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000740
Enrollment
Unknown
Registered
2025-04-14
Start date
2025-03-21
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

Treatment group:Western medicine standard therapy,warm acupuncture,cardiac rehabilitation training
Control group:Western medicine standard therapy,acupuncture

Sponsors

Pujiang Hospital of Minhang District Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Western medicine heart failure and the diagnostic criteria of traditional Chinese medicine heart failure syndrome aged between 18 and 75 years old male or female. 2. Patients with cardiac function grade II-III. 3. Patients with hemodynamic stability. 4. Study participants must have a history of acute myocardial infarction and the time interval should not be less than 3 months.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction acute coronary syndrome cardiac tamponade cardiogenic shock severe electrolyte imbalance and other factors that will increase mortality; 2. Patients with severe primary diseases and mental illness such as severe brain lesions (such as stroke advanced neurodegenerative diseases brain tumors) liver decompensated diseases (such as liver cirrhosis severe hepatitis liver cancer) end-stage renal disease (such as uremia rapidly progressive nephritis) malignant blood diseases (such as leukemia severe aplasia); 3. Women who are pregnant or preparing to become pregnant and lactating women; 4. Patients with previous sickness; 5. Subjects who cannot be included in the study as judged by the investigator;

Design outcomes

Primary

MeasureTime frame
MLHFQ;TCM Syndrome Points;

Secondary

MeasureTime frame
NT-proBNP;6 minutes walk experiment;(NYHA) cardiac function grading;

Countries

China

Contacts

Public Contactwenqing lv

Pujiang Hospital of Minhang District Shanghai

lwq9910102020@163.com15649685379

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026